Nicotine Replacement Therapy Market worth USD 3.54 billion by 2027; Increasing Cases of Smoking Cessation in North America to Stoke Exponential Demand

Ads

You May Also Like

Otonomy Initiates Phase 1 Clinical Trial for Tinnitus Product Candidate, OTO-311

SAN DIEGO, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical ...

Cellectar Biosciences Receives Japanese Patent for CLR 131 and CLR 125 for the Treatment of Cancer Stem Cells

MADISON, Wis., April 18, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), ...

TESARO to Announce Third-Quarter 2017 Financial Results on November 7, 2017

WALTHAM, Mass., Oct. 24, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its ...